-
1
-
-
34547852275
-
Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007
-
DOI 10.1093/annonc/mdm271
-
A Goldhirsch WC Wood RD Gelber, et al. 2007 Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007 Ann Oncol 18 1133 1144 1:STN:280:DC%2BD2svlvVSkuw%3D%3D 10.1093/annonc/mdm271 17675394 (Pubitemid 47244357)
-
(2007)
Annals of Oncology
, vol.18
, Issue.7
, pp. 1133-1144
-
-
Goldhirsch, A.1
Wood, W.C.2
Gelber, R.D.3
Coates, A.S.4
Thurlimann, B.5
Senn, H.-J.6
-
2
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
DOI 10.1016/S0140-6736(05)66544-0, PII S0140673605665440
-
Early Breast Cancer Trialists'Collaborative Group 2005 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687 1717 10.1016/S0140-6736(05)66544-0 (Pubitemid 40719106)
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
-
3
-
-
34447251650
-
Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?
-
DOI 10.1200/JCO.2007.11.3290
-
NL Henry DF Hayes 2007 Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy? J Clin Oncol 25 2501 2503 1:CAS:528:DC%2BD2sXotV2mt70%3D 10.1200/JCO.2007.11.3290 17577024 (Pubitemid 47041219)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.18
, pp. 2501-2503
-
-
Henry, N.L.1
Hayes, D.F.2
-
4
-
-
33645729203
-
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer
-
1:CAS:528:DC%2BD28XjsVeqs7k%3D 10.1001/jama.295.14.1658 16609087
-
DA Berry C Cirrincione IC Henderson, et al. 2006 Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer JAMA 295 1658 1667 1:CAS:528:DC%2BD28XjsVeqs7k%3D 10.1001/jama.295.14. 1658 16609087
-
(2006)
JAMA
, vol.295
, pp. 1658-1667
-
-
Berry, D.A.1
Cirrincione, C.2
Henderson, I.C.3
-
5
-
-
24144439984
-
ER expression is not bimodal in breast cancer
-
16196171
-
DC Allred SK Mohsin 2005 ER expression is not bimodal in breast cancer Am J Clin Pathol 124 474 475 16196171
-
(2005)
Am J Clin Pathol
, vol.124
, pp. 474-475
-
-
Allred, D.C.1
Mohsin, S.K.2
-
6
-
-
0037125429
-
Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: A randomized trial
-
International Breast Cancer Study Group
-
International Breast Cancer Study Group 2002 Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial J Natl Cancer Inst 94 1054 1065
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 1054-1065
-
-
-
7
-
-
17144369986
-
Concurrent versus sequential chemohormonal therapy versus tamoxifen alone for postmenopausal, node-positive, estrogen and/or progesterone receptor-positive breast cancer: Mature outcomes and new biologic correlates on phase III intergroup trial 0100
-
Abstract 37
-
Albain K, Barlow W, O'Malley F et al. (2004). Concurrent versus sequential chemohormonal therapy versus tamoxifen alone for postmenopausal, node-positive, estrogen and/or progesterone receptor-positive breast cancer: mature outcomes and new biologic correlates on phase III intergroup trial 0100. Breast Cancer Res Treat 88(suppl 1). Abstract 37
-
(2004)
Breast Cancer Res Treat
, vol.88
, Issue.SUPPL. 1
-
-
Albain, K.1
Barlow, W.2
O'Malley, F.3
-
8
-
-
9144242764
-
Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neoadjuvant anthracycline-based chemotherapy
-
DOI 10.1016/S0959-8049(03)00675-0
-
T Petit M Wilt M Velten, et al. 2004 Comparative value of tumour grade, hormonal receptors, Ki-67, HER-2 and topoisomerase II alpha status as predictive markers in breast cancer patients treated with neo-adjuvant anthracycline-based chemotherapy Eur J Cancer 40 205 211 1:CAS:528:DC%2BD2cXjsVOlsA%3D%3D 10.1016/S0959-8049(03)00675-0 14728934 (Pubitemid 38077022)
-
(2004)
European Journal of Cancer
, vol.40
, Issue.2
, pp. 205-211
-
-
Petit, T.1
Wilt, M.2
Velten, M.3
Millon, R.4
Rodier, J.-F.5
Borel, C.6
Mors, R.7
Haegele, P.8
Eber, M.9
Ghnassia, J.-P.10
-
9
-
-
33646375742
-
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: An update
-
DOI 10.1200/JCO.2005.02.6187
-
M Kaufmann GN Hortobagyi A Goldhirsch, et al. 2006 Recommendations from an international expert panel on the use of neoadjuvant systemic treatment of operable breast cancer: an update J Clin Oncol 24 1940 1949 10.1200/JCO.2005.02. 6187 16622270 (Pubitemid 46638994)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.12
, pp. 1940-1949
-
-
Kaufmann, M.1
Hortobagyi, G.N.2
Goldhirsch, A.3
Scholl, S.4
Makris, A.5
Valagussa, P.6
Blohmer, J.-U.7
Eiermann, W.8
Jackesz, R.9
Jonat, W.10
Lebeau, A.11
Loibl, S.12
Miller, W.13
Seeber, S.14
Semiglazov, V.15
Smith, R.16
Souchon, R.17
Stearns, V.18
Untch, M.19
Von Minckwitz, G.20
more..
-
10
-
-
33644973070
-
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors
-
DOI 10.1200/JCO.2005.02.6914
-
V Guarneri K Broglio SW Kau, et al. 2006 Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptors status and other factors J Clin Oncol 24 1037 1044 10.1200/JCO.2005.02.6914 16505422 (Pubitemid 46638799)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.7
, pp. 1037-1044
-
-
Guarneri, V.1
Broglio, K.2
Kau, S.-W.3
Cristofanilli, M.4
Buzdar, A.U.5
Valero, V.6
Buchholz, T.7
Meric, F.8
Middleton, L.9
Hortobagyi, G.N.10
Gonzalez-Angulo, A.M.11
-
11
-
-
33750310901
-
REporting recommendations for tumor MARKer prognostic studies (REMARK)
-
DOI 10.1007/s10549-006-9242-8
-
LM McShane DG Altman W Sauerbrei, et al. 2006 Reporting recommendations for tumor marker prognostic studies (REMARK) Breast Cancer Res Treat 100 229 235 10.1007/s10549-006-9242-8 16932852 (Pubitemid 44631925)
-
(2006)
Breast Cancer Research and Treatment
, vol.100
, Issue.2
, pp. 229-235
-
-
McShane, L.M.1
Altman, D.G.2
Sauerbrei, W.3
Taube, S.E.4
Gion, M.5
Clark, G.M.6
-
12
-
-
36849069347
-
American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer
-
DOI 10.1200/JCO.2007.14.2364
-
L Harris H Fritsche R Mennel, et al. 2007 American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer J Clin Oncol 25 5287 5312 1:CAS:528:DC%2BD2sXhsVKnsbzK 10.1200/JCO.2007.14.2364 17954709 (Pubitemid 350232263)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.33
, pp. 5287-5312
-
-
Harris, L.1
Fritsche, H.2
Mennel, R.3
Norton, L.4
Ravdin, P.5
Taube, S.6
Somerfield, M.R.7
Hayes, D.F.8
Bast Jr., R.C.9
-
13
-
-
0026072872
-
Pathological prognostic factors in breast cancer: The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
-
1:STN:280:DyaK38%2FpvVSltw%3D%3D 10.1111/j.1365-2559.1991.tb00229.x 1757079
-
CW Elston IO Ellis 1991 Pathological prognostic factors in breast cancer: the value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403 410 1:STN:280: DyaK38%2FpvVSltw%3D%3D 10.1111/j.1365-2559.1991.tb00229.x 1757079
-
(1991)
Histopathology
, vol.19
, pp. 403-410
-
-
Elston, C.W.1
Ellis, I.O.2
-
14
-
-
0031915998
-
Prognostic and predictive factors in breast cancer by immunohistochemical analysis
-
1:STN:280:DyaK1c7mtlaitg%3D%3D
-
DC Allred JM Harvey M Berardo, et al. 1998 Prognostic and predictive factors in breast cancer by immunohistochemical analysis Modern Pathol 11 155 168 1:STN:280:DyaK1c7mtlaitg%3D%3D
-
(1998)
Modern Pathol
, vol.11
, pp. 155-168
-
-
Allred, D.C.1
Harvey, J.M.2
Berardo, M.3
-
15
-
-
67649983962
-
Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer
-
1:CAS:528:DC%2BD1MXosVehs7w%3D 10.1200/JCO.2008.18.2808 19380452
-
F Penault-Llorca F André C Sagan, et al. 2009 Ki67 expression and docetaxel efficacy in patients with estrogen receptor-positive breast cancer J Clin Oncol 27 2809 2815 1:CAS:528:DC%2BD1MXosVehs7w%3D 10.1200/JCO.2008.18.2808 19380452
-
(2009)
J Clin Oncol
, vol.27
, pp. 2809-2815
-
-
Penault-Llorca, F.1
André, F.2
Sagan, C.3
-
16
-
-
0032190388
-
Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: The need for quality assurance
-
DOI 10.1016/S0959-8049(98)00149-X, PII S095980499800149X
-
DM Barnes RR Millis LV Beex, et al. 1998 Increased use of immunochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance Eur J Cancer 34 1677 1682 1:CAS:528:DyaK1cXntlShtbs%3D 10.1016/S0959-8049(98)00149-X 9893651 (Pubitemid 28474218)
-
(1998)
European Journal of Cancer
, vol.34
, Issue.11
, pp. 1677-1682
-
-
Barnes, D.M.1
Millis, R.R.2
Beex, L.V.A.M.3
Thorpe, S.M.4
Leake, R.E.5
-
17
-
-
20244374922
-
Ki-67 expression in breast carcinoma: Its association with grading systems, clinical parameters, and other prognostic factors - A surrogate marker?
-
DOI 10.1002/cncr.11188
-
H Trihia S Murray K Price, et al. 2003 Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors-a surrogate marker? Cancer 97 1321 1331 1:CAS:528: DC%2BD3sXisVKhuro%3D 10.1002/cncr.11188 12599241 (Pubitemid 36237320)
-
(2003)
Cancer
, vol.97
, Issue.5
, pp. 1321-1331
-
-
Trihia, H.1
Murray, S.2
Price, K.3
Gelber, R.D.4
Golouh, R.5
Goldhirsch, A.6
Coates, A.S.7
Collins, J.8
Castiglione-Gertsch, M.9
Gusterson, B.A.10
-
18
-
-
0034001886
-
Testing for erbB-2 by immunohistochemistry in breast cancer
-
1:CAS:528:DC%2BD3cXhtVWns7o%3D 10.1309/9X6X-1EL6-5QB1-YLD2 10664619
-
DC Allred PE Swanson 2000 Testing for erbB-2 by immunohistochemistry in breast cancer Am J Clin Pathol 113 171 175 1:CAS:528:DC%2BD3cXhtVWns7o%3D 10.1309/9X6X-1EL6-5QB1-YLD2 10664619
-
(2000)
Am J Clin Pathol
, vol.113
, pp. 171-175
-
-
Allred, D.C.1
Swanson, P.E.2
-
19
-
-
77954526150
-
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancers
-
10.1200/JCO.2009.25.6529 20404251
-
MEH Hammond DF Hayes M Dowsett, et al. 2010 American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancers J Clin Oncol 28 2784 2795 10.1200/JCO.2009.25.6529 20404251
-
(2010)
J Clin Oncol
, vol.28
, pp. 2784-2795
-
-
Hammond, M.E.H.1
Hayes, D.F.2
Dowsett, M.3
-
20
-
-
75249083420
-
Ki67 in breast cancer: Prognostic and predictive potential
-
1:CAS:528:DC%2BC3cXhtlGgtbc%3D 10.1016/S1470-2045(09)70262-1 20152769
-
R Yerushalmi R Woods PM Ravdin, et al. 2010 Ki67 in breast cancer: prognostic and predictive potential Lancet Oncol 11 174 183 1:CAS:528: DC%2BC3cXhtlGgtbc%3D 10.1016/S1470-2045(09)70262-1 20152769
-
(2010)
Lancet Oncol
, vol.11
, pp. 174-183
-
-
Yerushalmi, R.1
Woods, R.2
Ravdin, P.M.3
-
21
-
-
0037478605
-
Repeated observation of breast tumor subtypes in independent gene expression data sets
-
DOI 10.1073/pnas.0932692100
-
T Sorlie R Tibshirani J Parker, et al. 2003 Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418 8423 1:CAS:528:DC%2BD3sXlsFGntLk%3D 10.1073/pnas.0932692100 12829800 (Pubitemid 36842560)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.14
, pp. 8418-8423
-
-
Sorlie, T.1
Tibshirani, R.2
Parker, J.3
Hastie, T.4
Marron, J.S.5
Nobel, A.6
Deng, S.7
Johnsen, H.8
Pesich, R.9
Geisler, S.10
Demeter, J.11
Perou, C.M.12
Lonning, P.E.13
Brown, P.O.14
Borresen-Dale, A.-L.15
Botstein, D.16
-
22
-
-
33746910265
-
Concordance among gene-expression-based predictors for breast cancer
-
DOI 10.1056/NEJMoa052933
-
C Fan DS Oh L Wessels, et al. 2006 Concordance among gene-expression- based predictors for breast cancer N Engl J Med 355 560 569 1:CAS:528: DC%2BD28XotVKnur4%3D 10.1056/NEJMoa052933 16899776 (Pubitemid 44200649)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.6
, pp. 560-569
-
-
Fan, C.1
Oh, D.S.2
Wessels, L.3
Weigelt, B.4
Nuyten, D.S.A.5
Nobel, A.B.6
Van't Veer, L.J.7
Perou, C.M.8
-
23
-
-
66849140730
-
Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer
-
1:CAS:528:DC%2BD1MXmtlyit74%3D 10.1093/jnci/djp082 19436038
-
MCU Cheang SK Chia C Voduc, et al. 2009 Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 736 750 1:CAS:528:DC%2BD1MXmtlyit74%3D 10.1093/jnci/djp082 19436038
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 736-750
-
-
Cheang, M.C.U.1
Chia, S.K.2
Voduc, C.3
|